TCRT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alaunos Therapeutics Inc (TCRT) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, there are no significant positive catalysts or trading signals, and the financial performance shows declining revenue and EPS. Given the lack of strong growth trends and no clear upward momentum, holding off on investment is recommended until more favorable conditions arise.
The technical indicators are bearish. The MACD is negative and expanding downward, RSI is neutral at 35.649, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.917, with resistance at 3.089 and support at 2.745.
NULL identified. There is no recent news, no significant hedge fund or insider activity, and no recent congress trading data.
Declining revenue (-25% YoY) and EPS (-17.39% YoY) in the latest quarter (2025/Q4). The stock's technical indicators and lack of trading signals suggest bearish sentiment.
In 2025/Q4, revenue dropped by 25% YoY to 3000. Net income improved slightly (-893000, up 20.35% YoY), but EPS declined to -0.38 (-17.39% YoY). Gross margin remained flat at 100%. Overall, financial performance indicates weak growth trends.
No recent analyst rating or price target changes available for evaluation.
